Allogene Therapeutics, Inc. (ALLO) Revenue 2019–2025
Allogene Therapeutics, Inc. (ALLO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$0FY2025 · since FY2019: $0 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $22,000 | -76.8% |
| FY2023 | $95,000 | -39.1% |
| FY2022 | $156,000 | -99.9% |
| FY2021 | $114.1M | — |
| FY2020 | $0 | — |
| FY2019 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice